CeQur is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to stay on track with therapy and in control of their disease.
CeQur Announces Positive Results from Study Evaluating Simple Insulin Delivery Device Among People with Type 2 Diabetes
CeQur Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides
CeQur Receives CE Mark for PaQ Insulin Delivery Device
CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes